Cite

HARVARD Citation

    Tabouret, E. et al. (2021). TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study. Oncologist. pp. 647-e1304. [Online]. 
  
Back to record